GTX30922
|
GeneTex International Corporation
|
ImmunoHistoMount
|
|
IHC
|
|
HY-10015-10mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-10015-100mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-10015-25mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-10015-5mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-10015-50mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-100277-1mg
|
MedChemexpress LLC
|
Mifobate [CAS 76541-72-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-100277-5mg
|
MedChemexpress LLC
|
Mifobate [CAS 76541-72-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-100360-10mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
HY-100360-100mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
HY-100360-25mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
HY-100360-5mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
HY-100360-50mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
HY-100444-10mg
|
MedChemexpress LLC
|
SIS3 (free base) [CAS 521985-36-4]
|
|
COVID-19-immunoregulation
|
|
HY-100444-100mg
|
MedChemexpress LLC
|
SIS3 (free base) [CAS 521985-36-4]
|
|
COVID-19-immunoregulation
|
|
HY-100444-25mg
|
MedChemexpress LLC
|
SIS3 (free base) [CAS 521985-36-4]
|
|
COVID-19-immunoregulation
|
|
HY-100444-5mg
|
MedChemexpress LLC
|
SIS3 (free base) [CAS 521985-36-4]
|
|
COVID-19-immunoregulation
|
|
HY-100444-50mg
|
MedChemexpress LLC
|
SIS3 (free base) [CAS 521985-36-4]
|
|
COVID-19-immunoregulation
|
|
HY-100536-10mg
|
MedChemexpress LLC
|
IWP-3 [CAS 687561-60-0]
|
|
Cancer-programmed cell death
|
|
HY-100536-100mg
|
MedChemexpress LLC
|
IWP-3 [CAS 687561-60-0]
|
|
Cancer-programmed cell death
|
|
HY-100536-25mg
|
MedChemexpress LLC
|
IWP-3 [CAS 687561-60-0]
|
|
Cancer-programmed cell death
|
|
HY-100536-5mg
|
MedChemexpress LLC
|
IWP-3 [CAS 687561-60-0]
|
|
Cancer-programmed cell death
|
|
HY-100536-50mg
|
MedChemexpress LLC
|
IWP-3 [CAS 687561-60-0]
|
|
Cancer-programmed cell death
|
|
HY-100565-1mg
|
MedChemexpress LLC
|
SGC2085 [CAS 1821908-48-8]
|
|
Cancer-programmed cell death
|
|
HY-100565-10mg
|
MedChemexpress LLC
|
SGC2085 [CAS 1821908-48-8]
|
|
Cancer-programmed cell death
|
|